BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Proteomedix AG

Headquarters: Zurich, Switzerland
Website: N/A
Year Founded: 2010
Status: Acquired

BioCentury | Aug 22, 2016
Financial News

ProteoMediX completes venture financing

BioCentury | Feb 2, 2015
Financial News

ProteoMediX financial update

BioCentury | Apr 14, 2014
Financial News

ProteoMediX completes venture financing

BioCentury | Jun 4, 2012
Emerging Company Profile

ProteoMediX: Prostate's PI3K biomarkers

ProteoMediX PI3K blood test seeks to avoid unneeded biopsies for prostate cancer
BioCentury | Jan 23, 2012
Financial News

ProteoMediX completes venture financing

BioCentury | Jan 20, 2012
Financial News

ProteoMedix raises $2.7M in series A

BioCentury | Oct 31, 2011
Regulation

Lessons from PSA debate

Implications of PSA screening recommendation go beyond prostate cancer
BioCentury | Mar 3, 2011
Cover Story

Prostate's PTEN prognosis

BioCentury | Mar 3, 2011
Distillery Techniques

Technology: Markers

Items per page:
1 - 9 of 9
Help Center
Username
Request Training
Submit Data Correction
Ask a Question